Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial.
Saved in:
| Title: | Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial. |
|---|---|
| Authors: | Schreiber S; Department of Medicine I, University Hospital Schleswig-Holstein, Kiel University, Rosalind-Franklin-Strasse 12, 24105, Kiel, Germany. s.schreiber@mucosa.de., Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Danese S; Department of Gastroenterology, IRCCS San Raffaele Hospital and Vita-Salute University, Milan, Italy., Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA., Jeong AL; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Kim DH; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Lee YN; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Colombel JF; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. jean-frederic.colombel@mssm.edu. |
| Source: | Advances in therapy [Adv Ther] 2026 Jun; Vol. 43 (6), pp. 2510-2526. Date of Electronic Publication: 2026 Mar 30. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1865-8652 |
|---|---|
| DOI: | 10.1007/s12325-026-03533-3 |
